药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zopiclone
Benmoxin
The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Dabigatran etexilate.
Zopiclone
Toloxatone
The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Dabigatran etexilate.
Zopiclone
Pirlindole
The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Dabigatran etexilate.
Zopiclone
Hydracarbazine
The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Dabigatran etexilate.
Zopiclone
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Dabigatran etexilate.
Zopiclone
Nialamide
The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Dabigatran etexilate.
Zopiclone
Iproniazid
The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Dabigatran etexilate.
Zopiclone
Clorgiline
The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Dabigatran etexilate.
Zopiclone
Pargyline
The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Dabigatran etexilate.
Zopiclone
Rasagiline
The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Dabigatran etexilate.
Zopiclone
Isocarboxazid
The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Dabigatran etexilate.
Zopiclone
Potassium cation
Potassium cation may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Potassium
Potassium may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Bromotheophylline
Bromotheophylline may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Epitizide
Epitizide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Xipamide
Xipamide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Muzolimine
Muzolimine may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Clopamide
Clopamide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Fenquizone
Fenquizone may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.
Zopiclone
Clofenamide
Clofenamide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.